Isidro Juan Hernandez Alfonso
RAD-140 (also known as Testolone) is a SARM discovered in 2010 by Radius Health. It has been shown to have a greater anabolic effect than testosterone, giving greater muscle gains; but a lower androgenic effect, which means less side effects. When combined with testosterone, it amplifies its anabolic effects; but reduced its androgenic effects. This indicates that RAD-140 can make testosterone more effective at muscle building while making it less likely to cause unwanted side effects such as prostate enlargement.
RAD-140 seems to have a dose respondant effect, with increasing doses, increasing it’s effectiveness.
RAD-140 has a 90:1 anabolic to androgenic ratio as compared to testosterones 100:100. This means that while it is nearly as anabolic as testosterone, its is nowhere near as androgenic, which is a good thing as most of the side effects from testosterone come from the androgenic effects. This means that RAD140 has very few side effects.
RAD-140 has been studied for its neuroprotective effects, with indications that it could prevent brain and nerve cell death and injury - it is being considered as a possible treatment for Alzheimer's and neurodegenerative diseases.
RAD-140 can drastically improve an athletes’ endurance and recovery and promote strength gains.
RAD-140 is non-liver toxic and is very unlikely to cause suppression.
RAD-140 is best dosed 10-30mg per day and can be run for 12-14 weeks, first time users should stick to 8 week cycles.